BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9796553)

  • 21. Economics of antibiotic resistance.
    Sipahi OR
    Expert Rev Anti Infect Ther; 2008 Aug; 6(4):523-39. PubMed ID: 18662118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Bacteriologic and clinical analysis of nosocomial infections in patients from the intensive care unit].
    Nikodemski T
    Ann Acad Med Stetin; 1999; 45():211-26. PubMed ID: 10909491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions.
    Adang E; Voordijk L; Jan van der Wilt G; Ament A
    Health Policy; 2005 Oct; 74(2):146-56. PubMed ID: 16153475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health and economic impacts of antimicrobial resistance.
    Holmberg SD; Solomon SL; Blake PA
    Rev Infect Dis; 1987; 9(6):1065-78. PubMed ID: 3321356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short-duration therapy for respiratory tract infections.
    Goff DA
    Ann Pharmacother; 2004 Sep; 38(9 Suppl):S19-23. PubMed ID: 15226490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bug/drug resistance. Sometimes less is more.
    Phelps CE
    Med Care; 1989 Feb; 27(2):194-203. PubMed ID: 2918766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resistance to antibiotics: are we in the post-antibiotic era?
    Alanis AJ
    Arch Med Res; 2005; 36(6):697-705. PubMed ID: 16216651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ventilator-associated pneumonia complicating the acute respiratory distress syndrome.
    Iregui MG; Kollef MH
    Semin Respir Crit Care Med; 2001 Jun; 22(3):317-26. PubMed ID: 16088683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotic usage for respiratory tract infections in an era of rising resistance and increased cost pressure.
    Spiritus E
    Am J Manag Care; 2000 Dec; 6(23 Suppl):S1216-21. PubMed ID: 11187446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia.
    Feldman C
    J Lab Clin Med; 2004 May; 143(5):269-83. PubMed ID: 15122171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hospital-based strategies to reduce antibiotic resistance: are they valid in the community setting?
    Tillotson GS; Blondeau JM; Carroll J
    Expert Rev Anti Infect Ther; 2007 Feb; 5(1):53-9. PubMed ID: 17266453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical impact of antibiotic resistance in respiratory tract infections.
    Klugman KP
    Int J Antimicrob Agents; 2007 Feb; 29 Suppl 1():S6-10. PubMed ID: 17307654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rational approaches to combating resistance.
    Burke JP
    Int J Clin Pract Suppl; 2002 Mar; (125):29-36; discussion 37-9. PubMed ID: 12014855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Economic impact of a health care program on antibiotics].
    Susano R; Massalana A; Miranda ML
    Acta Med Port; 1998 Apr; 11(4):323-30. PubMed ID: 9644843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical effectiveness and costs of antibiotics in respiratory infections].
    Jahnz-Rózyk K
    Pol Merkur Lekarski; 2011 May; 30(179):327-9. PubMed ID: 21675134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness analysis of implementing an antimicrobial stewardship program in critical care units.
    Ruiz-Ramos J; Frasquet J; Romá E; Poveda-Andres JL; Salavert-Leti M; Castellanos A; Ramirez P
    J Med Econ; 2017 Jun; 20(6):652-659. PubMed ID: 28345481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Superbugs: should antimicrobial resistance be included as a cost in economic evaluation?
    Coast J; Smith RD; Millar MR
    Health Econ; 1996; 5(3):217-26. PubMed ID: 8817296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update: antibiotic therapy.
    King CH
    Compr Ther; 1988 Mar; 14(3):10-3. PubMed ID: 3129229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A decision analysis model in laboratory medicine--appropriate usage of microbiological examination in women with dysuria].
    Inoue Y
    Rinsho Byori; 1990 May; 38(5):587-92. PubMed ID: 2199709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Socio-economic and juridical aspects of nosocomial infections].
    Bocquet JP
    Bull Acad Natl Med; 1993 May; 177(5):739-46; discussion 746-7. PubMed ID: 8221176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.